PREVIOUS
✖
Zydus Cadila
July 5 , 2020
1391 days
817
0
- The Drugs Controller General of India (DGCI) has given its approval for the human clinical trials to the second indigenously developed COVID-19 vaccine by Zydus Cadila Healthcare Ltd.
- Headquartered in Gujarat’s Ahmedabad, Zydus Healthcare is one of the leading manufacturers of generic drugs in India.
Leave a Reply
Your Comment is awaiting moderation.